0

“Behind the Buzz” Show: XPhyto Therapeutics (CSE: XPHY) CEO & Director Hugh Rogers

XPhyto Therapeutics Corp. (CSE: XPHY) is a science-based cannabis company focused on formulation, clinical validation, and emerging European markets. XPhyto’s 100% owned German subsidiary, Bunker Pflanzenextrakte GmbH, has been granted a unique German cannabis cultivation and extraction licence for scientific purposes by the German Federal Institute for Drugs and Medical Devices (BfArM). XPhyto acquired 100% […]

0

“Buzz on the Street” Show: Amarantus Bioscience (OTC: AMBS) Patent to Treat Retinal Disorders

Amarantus Bioscience Holdings, Inc. (OTC: AMBS), a US-based JLABS-alumnus biotechnology holding company developing proprietary orphan neurologic, regenerative medicine and ophthalmic therapies and diagnostics through its subsidiaries, today announced that subsidiary MANF Therapeutics has been issued a Chinese patent covering the use of mesencephalic astrocyte-derived neurotrophic factor (MANF) and/or cerebral dopamine neurotrophic factor (CDNF) for the […]